MiR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 3, 2013, Pages 381-391

  Shi, Hong ^a   Sun, Bao liang ^b   Zhang, Jia ^a   Lu, Shiduo ^a   Zhang, Pengyue ^a   Wang, Hailian ^a   Yu, Qiong ^a   Stetler, R Anne ^a,c   Vosler, Peter S ^a,c   Chen, Jun ^a,c   Gao, Yanqin ^a  

^a FUDAN UNIVERSITY   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bcl 2; Cerebral ischemia; Microrna; Preconditioning; Sevoflurane

Indexed keywords

LENTIVIRUS VECTOR; MICRORNA; MICRORNA 15B; PROTEIN BCL 2; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; ISCHEMIC PRECONDITIONING; LASER DOPPLER FLOWMETRY; MALE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECTUM TEMPERATURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANESTHETICS, INHALATION; ANIMALS; BENZAMIDES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; INFUSIONS, INTRAVENTRICULAR; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; MALE; METHYL ETHERS; MICE, TRANSGENIC; MICRORNAS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SULFONES;

EID: 84878641281     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312030011     Document Type: Article

References (41)

1. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 2009, 10(10), 704-714.
2. Huang, Y.; Shen, X.J.; Zou, Q.; Wang, S.P.; Tang, S.M.; Zhang, G.Z. Biological functions of microRNAs: a review. J. Physiol. Biochem., 2011. 67(1), 129-139.
3. Benoit, M.E.; Tenner, A.J. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J. Neurosci., 2011, 31(9), 3459-3469.
4. Buller, B.; Liu, X.; Wang, X.; Zhang, R.L.; Zhang, L.; Hozeska-Solgot, A.; Chopp, M.; Zhang, Z.G. MicroRNA-21 protects neurons from ischemic death. FEBS J., 2010, 277(20), 4299-4307.
5. Lee, S.T.; Chu, K.; Jung, K.H.; Yoon, H.J.; Jeon, D.; Kang, K.M.; Park, K.H.; Bae, E.K.; Kim, M.; Lee, S.K.; Roh, J.K. MicroRNAs induced during ischemic preconditioning. Stroke, 2010, 41(8), 1646-1651.
6. Lusardi, T.A.; Farr, C.D.; Faulkner, C.L.; Pignataro, G.; Yang, T.; Lan, J.; Simon, R.P.; Saugstad, J.A. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab., 2010, 30(4), 744-756.
7. Sepramaniam, S.; Armugam, A.; Lim, K.Y.; Karolina, D.S.; Swaminathan, P.; Tan, J.R.; Jeyaseelan, K. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J. Biol. Chem., 2010, 285(38), 29223-29230.
8. Shi, H.; Li, P.; Liang, W.; Chen, J.; Gao, Y. Mechanisms of microRNA-mediated regulation of angiogenesis. Front. Biosci. (Elite Ed.), 2010, 2, 1304-1319.
9. Siegel, C.; Li, J.; Liu, F.; Benashski, S.E.; McCullough, L.D. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc. Natl. Acad. Sci. USA, 2011, 108(28), 11662-11667.
10. Weng, H.; Shen, C.; Hirokawa, G.; Ji, X.; Takahashi, R.; Shimada, K.; Kishimoto, C.; Iwai, N. Plasma miR-124 as a biomarker for cerebral infarction. Biomed. Res., 2011, 32(2), 135-141.
11. Yin, K.J.; Deng, Z.; Huang, H.; Hamblin, M.; Xie, C.; Zhang, J.; Chen, Y.E. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis., 2010, 38(1), 17-26.
12. Zeng, L.; Liu, J.; Wang, Y.; Wang, L.; Weng, S.; Tang, Y.; Zheng, C.; Cheng, Q.; Chen, S.; Yang, G.Y. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front. Biosci. (Elite Ed.), 2011, 3, 1265-1272.
13. Ziu, M.; Fletcher, L.; Rana, S.; Jimenez, D.F.; Digicaylioglu, M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One, 2011, 6(2), e14724.
14. Payne, R.S.; Akca, O.; Roewer, N.; Schurr, A.; Kehl, F. Sevofluraneinduced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res., 2005, 1034(1-2), 147-152.
15. Kehl, F.; Payne, R.S.; Roewer, N.; Schurr, A. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res., 2004, 1021(1), 76-81.
16. Luo, Y.; Ma, D.; Ieong, E.; Sanders, R.D.; Yu, B.; Hossain, M.; Maze, M. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology, 2008, 109(5), 782-789.
17. Sigaut, S.; Jannier, V.; Rouelle, D.; Gressens, P.; Mantz, J.; Dahmani, S. The preconditioning effect of sevoflurane on the oxygen glucosedeprived hippocampal slice: the role of tyrosine kinases and duration of ischemia. Anesth. Analg., 2009, 108(2), 601-608.
18. Velly, L.J.; Canas, P.T.; Guillet, B.A.; Labrande, C.N.; Masmejean, F.M.; Nieoullon, A.L.; Gouin, F.M.; Bruder, N.J.; Pisano, P.S. Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection. Anesth. Analg., 2009, 108(3), 955-963.
19. Wang, J.; Lei, B.; Popp, S.; Meng, F.; Cottrell, J.E.; Kass, I.S. Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia. Neuroscience, 2007, 145(3), 1097-1107.
20. Wang, S.; Dai, Z.G.; Dong, X.W.; Guo, S.X.; Liu, Y.; Wang, Z.P.; Zeng, Y.M. Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase. Neurosci. Bull., 2010, 26(6), 437-444.
21. Zitta, K.; Meybohm, P.; Bein, B.; Ohnesorge, H.; Steinfath, M.; Scholz, J.; Albrecht, M. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur. J. Pharmacol., 2010, 645(1-3), 39-46.
22. Adamczyk, S.; Robin, E.; Simerabet, M.; Kipnis, E.; Tavernier, B.; Vallet, B.; Bordet, R.; Lebuffe, G. Sevoflurane pre-and postconditioning protect the brain via the mitochondrial K ATP channel. Br. J. Anaesth., 2010, 104(2), 191-200.
23. Codaccioni, J.L.; Velly, L.J.; Moubarik, C.; Bruder, N.J.; Pisano, P.S.; Guillet, B.A. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology, 2009, 110(6), 1271-1278.
24. Wang, H.; Lu, S.; Yu, Q.; Liang, W.; Gao, H.; Li, P.; Gan, Y.; Chen, J.; Gao, Y. Sevoflurane preconditioning confers neuroprotection via antiinflammatory effects. Front. Biosci. (Elite Ed.), 2011, 3, 604-615.
25. Yang, Q.; Dong, H.; Deng, J.; Wang, Q.; Ye, R.; Li, X.; Hu, S.; Xiong, L. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth. Analg., 2011, 112(4), 931-937.
26. Ye, Z.; Guo, Q.; Wang, N.; Xia, P.; Yuan, Y.; Wang, E. Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. Neurol. Sci., 2012, 33(2), 239-249.
27. Yu, Q.; Chu, M.; Wang, H.; Lu, S.; Gao, H.; Li, P.; Gan, Y.; Shi, H.; Liang, W.; Chen, J.; Gao, Y. Sevoflurane preconditioning protects blood-brain-barrier against brain ischemia. Front. Biosci. (Elite Ed.), 2011, 3, 978-988.
28. Hanouz, J.L.; Zhu, L.; Lemoine, S.; Durand, C.; Lepage, O.; Massetti, M.; Khayat, A.; Plaud, B.; Gerard, J.L. Reactive oxygen species mediate sevoflurane-and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth. Analg., 2007, 105(6), 1534-1539.
29. Mattson, M.P.; Kumar, K.N.; Wang, H.; Cheng, B.; Michaelis, E.K. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci., 1993, 13(11), 4575-4588.
30. Cao, G.; Pei, W.; Lan, J.; Stetler, R.A.; Luo, Y.; Nagayama, T.; Graham, S.H.; Yin, X.M.; Simon, R.P.; Chen, J. Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures. J. Neurosci., 2001, 21(13), 4678-4690.
31. Chen, J.; Jin, K.; Chen, M.; Pei, W.; Kawaguchi, K.; Greenberg, D.A.; Simon, R. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J. Neurochem., 1997, 69(1), 232-245.
32. Halliwell, B.; Aruoma, O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett., 1991, 281(1-2), 9-19.
33. Yang, B.F.; Lu, Y.J.; Wang, Z.G. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin. Exp. Pharmacol. Physiol., 2009, 36(10), 951-960.
34. Guo, C.J.; Pan, Q.; Li, D.G.; Sun, H.; Liu, B.W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J. Hepatol., 2009, 50(4), 766-778.
35. Xia, L.; Zhang, D.; Du, R.; Pan, Y.; Zhao, L.; Sun, S.; Hong, L.; Liu, J.; Fan, D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer, 2008, 123(2), 372-379.
36. Willimott, S.; Wagner, S.D. Post-transcriptional and post-translational regulation of Bcl2. Biochem. Soc. Trans., 2010, 38(6), 1571-1575.
37. Chen, J.; Simon, R.P.; Nagayama, T.; Zhu, R.; Loeffert, J.E.; Watkins, S.C.; Graham, S.H. Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J. Cereb. Blood Flow Metab., 2000, 20(7), 1033-1039.
38. Shimizu, S.; Nagayama, T.; Jin, K.L.; Zhu, L.; Loeffert, J.E.; Watkins, S.C.; Graham, S.H.; Simon, R. bcl-2 Antisense treatment prevents induction of tolerance to focal ischemia in the rat brain. J. Cereb. Blood Flow Metab., 2001, 21(3), 233-243.
39. Cimmino, A.; Calin, G.A.; Fabbri, M.; Iorio, M.V.; Ferracin, M.; Shimizu, M.; Wojcik, S.E.; Aqeilan, R.I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C.G.; Kipps, T.J.; Negrini, M.; Croce, C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA, 2005, 102(39), 13944-13949.
40. Koerner, I.P.; Brambrink, A.M. Brain protection by anesthetic agents. Curr. Opin. Anaesthesiol., 2006, 19(5), 481-486.
41. Bienengraeber, M.W.; Weihrauch, D.; Kersten, J.R.; Pagel, P.S.; Warltier, D.C. Cardioprotection by volatile anesthetics. Vascul. Pharmacol., 2005, 42(5-6), 243-252.